Phoenix Holdings Ltd. Biomarin Pharmaceutical Inc Transaction History

Phoenix Holdings Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $1.91 Million - $2.37 Million	-25,675 Reduced 6.55%	366,364 $30.2 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $2.67 Million - $3.16 Million	31,882 Added 8.85%	392,039 $34.2 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $27.5 Million - $35.5 Million	360,157 New	360,157 $34.7 Million
Q4 2021 Feb 07, 2022	SELL	$71.72 - $91.47 $1.85 Million - $2.36 Million	-25,764 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$74.77 - $85.47 $434,189 - $496,324	-5,807 Reduced 18.39%	25,764 $1.97 Million
Q2 2021 Aug 10, 2021	BUY	$75.51 - $84.79 $325,146 - $365,105	4,306 Added 15.79%	31,571 $2.63 Million
Q1 2021 May 10, 2021	BUY	$74.73 - $90.69 $2.04 Million - $2.47 Million	27,265 New	27,265 $2.05 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.